Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)
636.12
+6.84 (1.09%)
Dec 22, 2025, 10:41 AM EST
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 648.5 billion as of December 24, 2025. Its market cap has decreased by -10.08% in one year.
Market Cap
648.50B
Enterprise Value
592.33B
Revenue
62.48B
Ranking
n/a
PE Ratio
33.11
Stock Price
636.12
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 83.36M to 648.50B, an increase of 777,860.91%. That is a compound annual growth rate of 29.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 645.91B | 0.70% |
| Dec 31, 2024 | 641.42B | 26.08% |
| Dec 29, 2023 | 508.76B | 29.82% |
| Dec 30, 2022 | 391.88B | 25.97% |
| Dec 31, 2021 | 311.09B | -2.53% |
| Dec 31, 2020 | 319.16B | 41.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 89.22B |
| Raia Drogasil | 39.93B |
| Hypera | 14.67B |
| Fleury | 7.98B |
| Odontoprev | 5.89B |
| Diagnósticos da América | 5.45B |
| Empreendimentos Pague Menos | 3.89B |
| Oncoclínicas do Brasil Serviços Médicos | 3.22B |